Ascendis Pharma A/S Sponsored ADR SEC filings and other documents

Explore the latest company documents and SEC filings from Ascendis Pharma A/S Sponsored ADR, including Forms 10-K, 10-Q, 8-K, and other key disclosures. Evaluate financial performance and operational updates to make more informed decisions.

Description

Event date

Documents and forms

2025

Q2 2025

Aug 7, 2025

Earnings release6-K

Transcript

Study Update

Jun 9, 2025

Press release

Slides

Investor Presentation

May 15, 2025

Slides

Q1 2025

May 1, 2025

Earnings release6-K

Earnings release8-K

Transcript

43rd Annual J.P. Morgan Healthcare Conference 2025

Jan 13, 2025

Slides

2024

Q4 2024

Feb 12, 2025

Annual report20-F

Earnings release8-K

Transcript

Q3 2024

Nov 14, 2024

Earnings release8-K

Investor Update

Sep 16, 2024

Press release

Slides

Q2 2024

Sep 3, 2024

Earnings release8-K

FDA Announcement

Aug 12, 2024

Press release

Slides

Q1 2024

May 2, 2024

Earnings release8-K

J.P. Morgan 42nd Annual Healthcare Conference 2024

Jan 8, 2024

Slides

2023

Q4 2023

Feb 7, 2024

Annual report20-F

Earnings release8-K

Q3 2023

Nov 7, 2023

Earnings release8-K

Q2 2023

Sep 5, 2023

Earnings release8-K

Status Update

May 31, 2023

Press release

Slides

FDA Announcement

May 1, 2023

Press release

Q1 2023

Apr 27, 2023

Earnings release8-K

Status Update

Apr 3, 2023

Press release

2022

Q4 2022

Feb 16, 2023

Annual report20-F

Earnings release8-K

2021

Q4 2021

Mar 2, 2022

Annual report10-K

2020

Q4 2020

Mar 10, 2021

Annual report10-K

2019

Q4 2019

Apr 3, 2020

Annual report10-K

2018

Q4 2018

Apr 3, 2019

Annual report10-K

2017

Q4 2017

Mar 28, 2018

Annual report10-K

2016

Q4 2016

Mar 22, 2017

Annual report10-K

2015

Q4 2015

Apr 15, 2016

Annual report10-K

2014

Q4 2014

Mar 26, 2015

Annual report10-K